Expression pattern of programmed death-1 in lymphocyte-rich classical Hodgkin lymphoma according to the growth patterns

被引:0
|
作者
Go, Jai Hyang [1 ]
机构
[1] Dankook Univ, Dept Pathol, Coll Med, Cheonan, Chungnam, South Korea
关键词
Hodgkin lymphoma; lymphocyte-rich; programmed death-1; T-CELLS; MICROENVIRONMENT; MARKER; PD-1;
D O I
10.4103/0377-4929.191819
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We present a rare case of lymphocyte-rich classical Hodgkin lymphoma ( LRCHL), which exhibited different expression patterns of programmed death-1 ( PD-1) in nodular and interfollicular areas. A 57-year-old male patient presented with neck masses. Neck computed tomography showed enlargement of multiple lymph nodes in right Level II and III. Histologic examination of the excised lymph node revealed LRCHL with nodular and interfollicular patterns. Immunohistochemical analysis for PD-1 revealed a small number of weakly stained cells in the interfollicular area. PD-1 (+) cells were markedly increased in cell number and staining intensity in the nodular area and formed rosettes around the tumor cells.
引用
收藏
页码:538 / 540
页数:3
相关论文
共 50 条
  • [21] Programmed death-1 (PD-1) and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma.
    Paydas, Semra
    Bagir, Emine
    Ergin, Melek
    Duman, Berna Bozkurt
    Ercolak, Vehbi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Expression of Programmed Cell Death-1 and Programmed Cell Death Ligands in Nodal Peripheral T-Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance
    Asawapanumas, Thiti
    Tangnantachai, Nichthida
    Sukswai, Narittee
    Assanasen, Thammathorn
    Chanswangphuwana, Chantiya
    Lawsut, Panisinee
    Polprasert, Chantana
    Rojnuckarin, Ponlapat
    Bunworasate, Udomsak
    Wudhikarn, Kitsada
    ACTA HAEMATOLOGICA, 2022, 145 (05) : 542 - 552
  • [23] Lymphocyte-rich Classical Hodgkin's Lymphoma (LRCHL) mimicking Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL, NOS)
    Nifora, M.
    Aroukatos, P.
    Kotsikogianni, I.
    Panopoulou, E.
    Zikos, P.
    VIRCHOWS ARCHIV, 2015, 467 : S201 - S201
  • [24] Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma
    Paydas, Semra
    Bagir, Emine
    Seydaoglu, Gulsah
    Ercolak, Vehbi
    Ergin, Melek
    ANNALS OF HEMATOLOGY, 2015, 94 (09) : 1545 - 1552
  • [25] Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma
    Semra Paydas
    Emine Bağır
    Gulsah Seydaoglu
    Vehbi Ercolak
    Melek Ergin
    Annals of Hematology, 2015, 94 : 1545 - 1552
  • [26] Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's lymphoma
    Schnell, Roland
    Dietlein, Markus
    Schomaecker, Klaus
    Kobe, Carsten
    Borchmann, Peter
    Schicha, Harald
    Hallek, Michael
    Engert, Andreas
    ONKOLOGIE, 2008, 31 (1-2): : 49 - 51
  • [27] Analysis of Immune-Related Adverse Reactions in Patients with Classical Hodgkin Lymphoma (cHL) on Programmed Death-1 (PD-1) Inhibitor Therapy
    Brave, Michael
    Liu, Jinzhong
    Przepiorka, Donna
    Blumenthal, Gideon
    Miller, Barry W.
    BLOOD, 2018, 132
  • [28] Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis
    Churchill, Hywyn R. O.
    Roncador, Giovanna
    Warnke, Roger A.
    Natkunam, Yasodha
    HUMAN PATHOLOGY, 2010, 41 (12) : 1726 - 1734
  • [29] Lymphocyte-rich classical Hodgkin's lymphoma: Clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group Trials
    Shimabukuro-Vornhagen, A
    Haverkamp, H
    Engert, A
    Balleisen, L
    Majunke, P
    Heil, G
    Eich, HT
    Stein, H
    Diehl, V
    Josting, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5739 - 5745
  • [30] Differential expression of programmed death-1 according to the histological differentiation of cutaneous squamous cell carcinoma
    Oh, S. T.
    Yang, K. J.
    Lee, J. -U.
    Bae, J. M.
    Park, H. J.
    Kim, J. W.
    Park, Y. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (03) : 628 - 629